D. Ross

发表

Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

P. Miller, M. McClung, A. Kaunitz, 2006, Contraception.

Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.

P. Darney, K. Wolter, L. Speroff, 2009, Contraception.

Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.

S. Carson, W. Schlaff, A. Bergqvist, 2006, Fertility and sterility.

Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg.

C. Brucker, A. Ray, J. Jain, 2006, Contraception.

Suppression of ovulation by a new subcutaneous depot medroxyprogesterone acetate (104 mg/0.65 mL) contraceptive formulation in Asian women.

F. Bode, J. Jain, D. Ross, 2004, Clinical therapeutics.

Contraceptive efficacy and safety of DMPA-SC.

A. Kaunitz, A. Jakimiuk, F. Bode, 2004, Contraception.

The role of training in effective simulated self-injection of subcutaneous depot medroxyprogesterone acetate: observations from a usability study.

K. Wolter, D. Morgenstern, F. Hilton, 2016, Contraception.

Use of Depot Medroxyprogesterone Acetate Contraception and Incidence of Bone Fracture

K. Rothman, K. Wolter, L. McQuay, 2013, Obstetrics and gynecology.